Friday, October 29, 2021
HomeUterine And Endometrial CancerLenvatinib-pembrolizumab combination extends PFS, OS in advanced endometrial cancer

Lenvatinib-pembrolizumab combination extends PFS, OS in advanced endometrial cancer

March 22, 2021

3 minutes read


Makker V, et cetera. Intellectual11512 Culture of Gynecologic Oncology Yearly Getting to know on Female’s Cancer cells (digital conference); March 19-25, 2021.

Makker files study backing to her establishment coming from or even consultant/advisory duties along with AstraZeneca, Clovis Oncology, Eisai, Genentech, Karyopharm Rehabs, Merck, Mereo BioPharma, Takeda and also Zymeworks. Desire discover the intellectual for all various other scientists’ pertinent economic acknowledgments.

Source link

Endometrial Cancer Integrative Robotic Surgery

There is a new way to treat endometrial, and other uterine cancers, using robotic surgery, targeted molecular therapies where needed, and integrative holistic support.  It might help you to review your 21st century options:  Uterine Endometrial Cancer Treatment Options

- Advertisment -

Most Popular

Recent Comments